Twelve years ago, University of Adelaide researcher Dr Mohammed Alsharifi began experimenting with a vaccine against Streptococcus pneumoniae, a bacteria commonly found in the nose and throat, and responsible for life-threatening illnesses such as sepsis, pneumonia and meningitis.